Merck & Co. Inc. (NYSE:MRK) is one of the best growth stocks to buy now. On October 7, Merck & Co. announced the completion of its acquisition of Verona Pharma (NASDAQ:VRNA). Verona Pharma is now a wholly-owned subsidiary of Merck. The acquisition is valued at ~$10 billion and was executed under the terms of an agreement where Merck, through a subsidiary, acquired all outstanding shares of Verona Pharma. The acquisition strengthens and complements Merck’s cardio-pulmonary portfolio with the addition of Oh ...